Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France. As France ordered 94 million doses of vaccine in response to the A(H1N1) pandemic, France begun on October 20, 2009 vaccinating key medical workers against swine flu and will continue the preventing campaign for the general population early next month. Getty Images logo Getty Images 1 month ago

Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France. As France ordered 94 million doses of vaccine in response to the A(H1N1) pandemic, France begun on October 20, 2009 vaccinating key medical workers against swine flu and will continue the preventing campaign for the general population early next month.